Literature DB >> 8424525

Ketorolac, nasal polyposis, and bronchial asthma: a cause for concern.

G R Haddow1, E Riley, R Isaacs, R McSharry.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8424525

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


× No keyword cloud information.
  4 in total

Review 1.  Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management.

Authors:  J C Gillis; R N Brogden
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

Review 2.  Minimising the adverse effects of ketorolac.

Authors:  D I Reinhart
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

3.  Severe ketorolac-induced asthma diagnosed by chest computed tomography.

Authors:  Vânia Fernandes; Tiago M Alfaro; João P Baptista; Frederico S Regateiro; Fátima Fradinho; Carlos Robalo Cordeiro
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

Review 4.  A risk-benefit appraisal of injectable NSAIDs in the management of postoperative pain.

Authors:  L S Nuutinen; J O Laitinen; T E Salomäki
Journal:  Drug Saf       Date:  1993-11       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.